# Finero

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/finero

- Industry: Industrial Machinery
- Headquarters: Shanghai, China
- Website: www.finern.com
- Total disclosed funding: $7.3M
- Latest round: Series A (Jul 28, 2022)
- Investors on record: 7

## About

Based in Shanghai, China and established in 2011, FINERO operates as an intelligent plant service provider that provides automation manufacturing solutions. The core research team of the company has approximately 70% members of its total employees and has bachelor degree. The company passed ISO9001:2015 quality management system certification in February 2017. The company has R&D centers located in Shanghai, Shenzhen and Wuhan. In August 2017, The company established Finern International (Hong Kong) Ltd. Fei Han is the CEO of the company.

The company provides automation manufacturing solutions for intelligent manufacturing industry, including test, control and smart plant. The company also provides technical support and business consulting. The company's solutions include automotive electronics, 3C electronics, new energy, intelligent warehouse, medical health. Automotive electronics include auto motor assembly line, radar assembly line and temperature sensor assembly line. Medical health include reagent filling line, syringe & needle assembly line and diagnostic test strip assembly line. The company has 27 utility model patents, 3 design patents and 34 computer software copyrights.

## Funding rounds

- Series A, Jul 28, 2022 — Oriza Holdings, China Fortune-Tech Capital, Yubo Investment, NVA Capital, Lingang Songjiang Capital, China Tongren Bio-Pharmaceutical
- Series A, Nov 20, 2016, $7.3M — Qiming Venture Partners

## Investors

- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series A
- Oriza Holdings (https://capitalatlas.ai/funds/oriza-holdings) — Series A
- China Fortune-Tech Capital (https://capitalatlas.ai/funds/china-fortune-tech-capital) — Series A
- Yubo Investment (https://capitalatlas.ai/funds/yubo-investment) — Series A
- NVA Capital (https://capitalatlas.ai/funds/nva-capital) — Series A
- Lingang Songjiang Capital (https://capitalatlas.ai/funds/lingang-songjiang-capital) — Series A
- China Tongren Bio-Pharmaceutical — Series A